Anika Therapeutics, Inc. (ANIK)
USD 14.13
(-3.81%)
USD 14.13
(-3.81%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 46.38 Million USD | 16.65% |
| 2022 | 39.76 Million USD | 10.43% |
| 2021 | 36.01 Million USD | -22.07% |
| 2020 | 46.2 Million USD | 110.09% |
| 2019 | 21.99 Million USD | 3.26% |
| 2018 | 21.3 Million USD | -3.34% |
| 2017 | 22.03 Million USD | 37.87% |
| 2016 | 15.98 Million USD | 7.0% |
| 2015 | 14.93 Million USD | 20.4% |
| 2014 | 12.4 Million USD | 12.82% |
| 2013 | 10.99 Million USD | 32.76% |
| 2012 | 8.28 Million USD | 13.43% |
| 2011 | 7.3 Million USD | -18.41% |
| 2010 | 8.94 Million USD | 6.03% |
| 2009 | 8.44 Million USD | 52.92% |
| 2008 | 5.51 Million USD | 25.73% |
| 2007 | 4.39 Million USD | -18.64% |
| 2006 | 5.39 Million USD | 64.95% |
| 2005 | 3.27 Million USD | -22.62% |
| 2004 | 4.22 Million USD | 16.54% |
| 2003 | 3.62 Million USD | 24.04% |
| 2002 | 2.92 Million USD | -21.54% |
| 2001 | 3.72 Million USD | -21.33% |
| 2000 | 4.73 Million USD | -13.86% |
| 1999 | 5.5 Million USD | 57.14% |
| 1998 | 3.5 Million USD | 40.0% |
| 1997 | 2.5 Million USD | 0.0% |
| 1996 | 2.5 Million USD | -24.24% |
| 1995 | 3.3 Million USD | -2.94% |
| 1994 | 3.4 Million USD | 30.77% |
| 1993 | 2.6 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 51.46 Million USD | 4.16% |
| 2024 Q1 | 49.4 Million USD | 6.51% |
| 2024 Q3 | 39.62 Million USD | -23.0% |
| 2023 Q2 | 42.6 Million USD | 3.11% |
| 2023 Q1 | 41.31 Million USD | 3.91% |
| 2023 FY | 46.38 Million USD | 16.65% |
| 2023 Q4 | 46.38 Million USD | 6.09% |
| 2023 Q3 | 43.72 Million USD | 2.63% |
| 2022 FY | 39.76 Million USD | 10.43% |
| 2022 Q4 | 39.76 Million USD | 6.79% |
| 2022 Q2 | 35.33 Million USD | 0.32% |
| 2022 Q1 | 35.22 Million USD | -2.18% |
| 2022 Q3 | 37.23 Million USD | 5.38% |
| 2021 Q4 | 36.01 Million USD | 2.83% |
| 2021 FY | 36.01 Million USD | -22.07% |
| 2021 Q1 | 42.71 Million USD | -7.55% |
| 2021 Q2 | 42.85 Million USD | 0.33% |
| 2021 Q3 | 35.01 Million USD | -18.29% |
| 2020 Q1 | 35.08 Million USD | 59.5% |
| 2020 Q2 | 46.47 Million USD | 32.49% |
| 2020 Q3 | 47.88 Million USD | 3.02% |
| 2020 Q4 | 46.2 Million USD | -3.49% |
| 2020 FY | 46.2 Million USD | 110.09% |
| 2019 Q2 | 22.98 Million USD | 1.63% |
| 2019 Q1 | 22.61 Million USD | 6.18% |
| 2019 Q4 | 21.99 Million USD | -12.87% |
| 2019 Q3 | 25.24 Million USD | 9.82% |
| 2019 FY | 21.99 Million USD | 3.26% |
| 2018 Q3 | 23.82 Million USD | -0.96% |
| 2018 Q2 | 24.06 Million USD | 5.67% |
| 2018 FY | 21.3 Million USD | -3.34% |
| 2018 Q1 | 22.77 Million USD | 3.34% |
| 2018 Q4 | 21.3 Million USD | -10.61% |
| 2017 Q4 | 22.03 Million USD | 8.8% |
| 2017 Q2 | 17.58 Million USD | 8.68% |
| 2017 Q3 | 20.25 Million USD | 15.17% |
| 2017 Q1 | 16.18 Million USD | 1.23% |
| 2017 FY | 22.03 Million USD | 37.87% |
| 2016 Q2 | 17.26 Million USD | 9.51% |
| 2016 Q3 | 18.02 Million USD | 4.38% |
| 2016 FY | 15.98 Million USD | 7.0% |
| 2016 Q1 | 15.76 Million USD | 5.54% |
| 2016 Q4 | 15.98 Million USD | -11.3% |
| 2015 Q4 | 14.93 Million USD | 23.71% |
| 2015 Q3 | 12.07 Million USD | 3.05% |
| 2015 FY | 14.93 Million USD | 20.4% |
| 2015 Q1 | 12.51 Million USD | 0.88% |
| 2015 Q2 | 11.71 Million USD | -6.37% |
| 2014 Q3 | 13.58 Million USD | -2.03% |
| 2014 Q2 | 13.86 Million USD | 6.8% |
| 2014 Q4 | 12.4 Million USD | -8.66% |
| 2014 Q1 | 12.98 Million USD | 18.05% |
| 2014 FY | 12.4 Million USD | 12.82% |
| 2013 Q1 | 9.94 Million USD | 20.09% |
| 2013 Q4 | 10.99 Million USD | -5.06% |
| 2013 Q3 | 11.58 Million USD | 11.82% |
| 2013 Q2 | 10.35 Million USD | 4.12% |
| 2013 FY | 10.99 Million USD | 32.76% |
| 2012 FY | 8.28 Million USD | 13.43% |
| 2012 Q2 | 10.77 Million USD | 18.68% |
| 2012 Q4 | 8.28 Million USD | -7.27% |
| 2012 Q3 | 8.93 Million USD | -17.11% |
| 2012 Q1 | 9.08 Million USD | 24.35% |
| 2011 FY | 7.3 Million USD | -18.41% |
| 2011 Q4 | 7.3 Million USD | -7.26% |
| 2011 Q3 | 7.87 Million USD | -14.15% |
| 2011 Q2 | 9.17 Million USD | 4.54% |
| 2011 Q1 | 8.77 Million USD | -1.97% |
| 2010 FY | 8.94 Million USD | 6.03% |
| 2010 Q2 | 8.36 Million USD | -4.73% |
| 2010 Q3 | 9.39 Million USD | 12.25% |
| 2010 Q1 | 8.78 Million USD | 4.08% |
| 2010 Q4 | 8.94 Million USD | -4.74% |
| 2009 Q3 | 6.95 Million USD | -4.84% |
| 2009 FY | 8.44 Million USD | 52.92% |
| 2009 Q2 | 7.3 Million USD | 23.86% |
| 2009 Q1 | 5.89 Million USD | 6.84% |
| 2009 Q4 | 8.44 Million USD | 21.43% |
| 2008 Q3 | 5.04 Million USD | 5.4% |
| 2008 Q4 | 5.51 Million USD | 9.51% |
| 2008 FY | 5.51 Million USD | 25.73% |
| 2008 Q1 | 5.36 Million USD | 22.29% |
| 2008 Q2 | 4.78 Million USD | -10.92% |
| 2007 Q4 | 4.39 Million USD | -6.84% |
| 2007 Q2 | 5.53 Million USD | -7.45% |
| 2007 Q1 | 5.98 Million USD | 10.9% |
| 2007 Q3 | 4.71 Million USD | -14.9% |
| 2007 FY | 4.39 Million USD | -18.64% |
| 2006 FY | 5.39 Million USD | 64.95% |
| 2006 Q2 | 4.43 Million USD | 26.68% |
| 2006 Q3 | 5.6 Million USD | 26.35% |
| 2006 Q4 | 5.39 Million USD | -3.71% |
| 2006 Q1 | 3.5 Million USD | 7.03% |
| 2005 Q2 | 4.03 Million USD | 7.25% |
| 2005 Q3 | 3.34 Million USD | -17.14% |
| 2005 Q4 | 3.27 Million USD | -2.21% |
| 2005 Q1 | 3.76 Million USD | -10.95% |
| 2005 FY | 3.27 Million USD | -22.62% |
| 2004 Q1 | 3.62 Million USD | -0.14% |
| 2004 Q4 | 4.22 Million USD | 1.46% |
| 2004 Q3 | 4.16 Million USD | 11.12% |
| 2004 Q2 | 3.74 Million USD | 3.51% |
| 2004 FY | 4.22 Million USD | 16.54% |
| 2003 Q4 | 3.62 Million USD | 8.53% |
| 2003 Q1 | 3.17 Million USD | 8.55% |
| 2003 Q2 | 3.22 Million USD | 1.7% |
| 2003 FY | 3.62 Million USD | 24.04% |
| 2003 Q3 | 3.34 Million USD | 3.53% |
| 2002 FY | 2.92 Million USD | -21.54% |
| 2002 Q4 | 2.92 Million USD | 5.32% |
| 2002 Q3 | 2.77 Million USD | -0.37% |
| 2002 Q1 | 3.16 Million USD | -15.04% |
| 2002 Q2 | 2.78 Million USD | -11.99% |
| 2001 FY | 3.72 Million USD | -21.33% |
| 2001 Q1 | 4.77 Million USD | 0.83% |
| 2001 Q2 | 4.62 Million USD | -3.19% |
| 2001 Q3 | 3.93 Million USD | -14.93% |
| 2001 Q4 | 3.72 Million USD | -5.27% |
| 2000 Q4 | 4.73 Million USD | -27.85% |
| 2000 Q1 | 6.79 Million USD | 23.51% |
| 2000 FY | 4.73 Million USD | -13.86% |
| 2000 Q2 | 7.23 Million USD | 6.5% |
| 2000 Q3 | 6.56 Million USD | -9.24% |
| 1999 Q4 | 5.5 Million USD | 30.95% |
| 1999 FY | 5.5 Million USD | 57.14% |
| 1999 Q3 | 4.2 Million USD | 5.0% |
| 1999 Q1 | 3.5 Million USD | 0.0% |
| 1999 Q2 | 4 Million USD | 14.29% |
| 1998 Q3 | 3.3 Million USD | 17.86% |
| 1998 Q1 | 2.8 Million USD | 12.0% |
| 1998 Q2 | 2.8 Million USD | 0.0% |
| 1998 Q4 | 3.5 Million USD | 6.06% |
| 1998 FY | 3.5 Million USD | 40.0% |
| 1997 Q3 | 2.7 Million USD | 12.5% |
| 1997 Q1 | 2.5 Million USD | -3.85% |
| 1997 FY | 2.5 Million USD | 0.0% |
| 1997 Q2 | 2.4 Million USD | -4.0% |
| 1997 Q4 | 2.5 Million USD | -7.41% |
| 1996 Q4 | 2.6 Million USD | 4.0% |
| 1996 Q2 | 2.9 Million USD | -6.45% |
| 1996 Q1 | 3.1 Million USD | -3.13% |
| 1996 FY | 2.5 Million USD | -24.24% |
| 1996 Q3 | 2.5 Million USD | -13.79% |
| 1995 Q3 | 3.3 Million USD | -8.33% |
| 1995 Q4 | 3.2 Million USD | -3.03% |
| 1995 Q1 | 3.7 Million USD | 12.12% |
| 1995 Q2 | 3.6 Million USD | -2.7% |
| 1995 FY | 3.3 Million USD | -2.94% |
| 1994 FY | 3.4 Million USD | 30.77% |
| 1994 Q1 | 2.9 Million USD | 7.41% |
| 1994 Q3 | 3.4 Million USD | 9.68% |
| 1994 Q4 | 3.3 Million USD | -2.94% |
| 1994 Q2 | 3.1 Million USD | 6.9% |
| 1993 FY | 2.6 Million USD | 0.0% |
| 1993 Q3 | 2.6 Million USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q4 | 2.7 Million USD | 3.85% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -1301.39% |
| BrainsWay Ltd. | 3.71 Million USD | -1147.942% |
| Cerus Corporation | 39.86 Million USD | -16.349% |
| Envoy Medical, Inc. | 1.4 Million USD | -3203.846% |
| electroCore, Inc. | 2.16 Million USD | -2047.5% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -10050.109% |
| IceCure Medical Ltd | 2.27 Million USD | -1938.945% |
| Inogen, Inc. | 21.84 Million USD | -112.39% |
| OrthoPediatrics Corp. | 105.85 Million USD | 56.178% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -16585.612% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -4638599900.0% |
| MaxCyte, Inc. | 12.22 Million USD | -279.311% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -2586.418% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -29554.776% |
| Orthofix Medical Inc. | 222.16 Million USD | 79.121% |
| PAVmed Inc | 1.01 Million USD | -4461.066% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | -132.383% |
| RxSight, Inc. | 17.42 Million USD | -166.265% |
| Sight Sciences, Inc. | 7.84 Million USD | -490.98% |
| SI-BONE, Inc. | 20.24 Million USD | -129.078% |
| TELA Bio, Inc. | 13.16 Million USD | -252.424% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | -58.612% |
| Vivos Therapeutics, Inc. | 1.00 USD | -4638599900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -984.292% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -20067.826% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -1868.846% |
| CVRx, Inc. | 10.98 Million USD | -322.344% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -11791.529% |
| Bioventus Inc. | 91.33 Million USD | 49.212% |
| Venus Concept Inc. | 28.67 Million USD | -61.759% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -1722.633% |
| LivaNova PLC | 147.88 Million USD | 68.634% |
| 908 Devices Inc. | 14.93 Million USD | -210.523% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 66.103% |
| Nemaura Medical Inc. | 1.75 Million USD | -2543.3% |
| NeuroPace, Inc. | 11.21 Million USD | -313.644% |
| LENSAR, Inc. | 15.68 Million USD | -195.659% |
| Apyx Medical Corporation | 9.92 Million USD | -367.459% |
| Cutera, Inc. | 72.1 Million USD | 35.665% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -1635.354% |
| BioSig Technologies, Inc. | -103 Thousand USD | 45134.951% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -486.348% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 88.094% |
| Axonics, Inc. | 79.94 Million USD | 41.974% |
| Outset Medical, Inc. | 49.21 Million USD | 5.748% |
| IRIDEX Corporation | 9.9 Million USD | -368.262% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | -16.677% |
| IRadimed Corporation | 12.82 Million USD | -261.792% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -6035.714% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -17436.776% |
| Telesis Bio, Inc. | 4.02 Million USD | -1052.447% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -907.445% |
| Varex Imaging Corporation | 277.5 Million USD | 83.284% |
| Quipt Home Medical Corp. | 18.32 Million USD | -153.119% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | -177.047% |
| Dynatronics Corporation | 5.59 Million USD | -729.214% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -1139.936% |
| Semler Scientific, Inc. | 445 Thousand USD | -10323.82% |
| InMode Ltd. | 45.09 Million USD | -2.863% |
| Bruker Corporation | 968.3 Million USD | 95.21% |
| Cytosorbents Corporation | 3.68 Million USD | -1160.445% |
| DexCom, Inc. | 559.6 Million USD | 91.711% |
| Align Technology, Inc. | 296.9 Million USD | 84.377% |
| Viveve Medical, Inc. | 1.47 Million USD | -3051.223% |
| ZimVie Inc. | 79.6 Million USD | 41.726% |
| Movano Inc. | 1.51 Million USD | -2965.829% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 23.804% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -29554.776% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 70.63% |
| Profound Medical Corp. | 6.95 Million USD | -567.113% |
| Insulet Corporation | 402.6 Million USD | 88.478% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | -212.595% |
| iCAD, Inc. | 917 Thousand USD | -4958.451% |
| Nuwellis, Inc. | 1.99 Million USD | -2222.784% |
| Biotricity, Inc. | 1.87 Million USD | -2368.125% |
| iRhythm Technologies, Inc. | 13.97 Million USD | -231.969% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -2102.564% |
| PAVmed Inc. | 1.01 Million USD | -4461.066% |
| BIOLASE, Inc. | 11.43 Million USD | -305.72% |
| Beyond Air, Inc. | 2.12 Million USD | -2080.818% |
| FONAR Corporation | 2.71 Million USD | -1608.231% |
| AxoGen, Inc. | 23.02 Million USD | -101.503% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | -105.913% |
| Inari Medical, Inc. | 42.9 Million USD | -8.126% |
| UFP Technologies, Inc. | 70.19 Million USD | 33.915% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -7272.465% |
| Tenon Medical, Inc. | 554 Thousand USD | -8272.924% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -2686.406% |
| AdaptHealth Corp. | 113.64 Million USD | 59.182% |
| Sintx Technologies, Inc. | 888 Thousand USD | -5123.649% |
| NanoVibronix, Inc. | 2.73 Million USD | -1597.877% |
| Quanterix Corporation | 22.36 Million USD | -107.404% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | -212.427% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 18.156% |
| TransMedics Group, Inc. | 44.23 Million USD | -4.863% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -720.555% |
| NeuroMetrix, Inc. | 1.55 Million USD | -2874.552% |
| Hyperfine, Inc. | 6.58 Million USD | -604.74% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 41.973% |
| Biomerica, Inc. | 2.37 Million USD | -1852.273% |
| Bone Biologics Corporation | -328.84 Thousand USD | 14205.777% |
| AVITA Medical, Inc. | 3.12 Million USD | -1386.058% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | -55.262% |